Global Stented Biological Valve Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Stented Biological Valve market size was valued at US$ 3113 million in 2024 and is forecast to a readjusted size of USD 4617 million by 2031 with a CAGR of 5.8% during review period.
A Stented Biological Valve is a type of bioprosthetic heart valve that incorporates a metallic or polymeric stent to hold the valve in place. These valves are made from animal tissues (bovine or porcine) and are designed for patients who require a valve replacement but do not wish to take long-term anticoagulants.
Market Overview:
Stented biological valves are among the most commonly used valves in heart valve replacement surgeries. They are widely used due to their natural function, low risk of thromboembolic events, and favorable clinical outcomes. The addition of a stent allows for easier implantation, particularly in older patients and those undergoing transcatheter procedures.
Market Drivers:
Preference for biological valves over mechanical valves due to their natural function and reduced need for anticoagulation.
Increasing adoption of minimally invasive approaches like TAVR, where stented biological valves are often preferred.
Aging populations and the rising incidence of valvular heart disease.
Market Opportunities:
Expanding indications for the use of stented biological valves in various procedures, particularly in lower-risk patient populations.
Research into improving the longevity and anti-calcification properties of stented valves.
Market Limitations:
Limited durability compared to mechanical valves, which may require reoperation in younger patients.
Concerns about the risk of degeneration and calcification, particularly in patients under 65 years old.
Market Trends:
Greater adoption of TAVR procedures, leading to a rise in the use of stented biological valves.
Ongoing improvements in the durability and biocompatibility of stented biological valves.
This report is a detailed and comprehensive analysis for global Stented Biological Valve market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Stented Biological Valve market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Stented Biological Valve
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Stented Biological Valve market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Edwards Lifesciences, St. Jude Medical, Meril Life Sciences, Boston Scientific, Labor, Abbott, Colibri Heart Valve, Balance Medical, Venus Medtech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Stented Biological Valve market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Surgical Valve
Interventional Valve
Market segment by Application
Hospital
Clinic
Other
Major players covered
Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Boston Scientific
Labor
Abbott
Colibri Heart Valve
Balance Medical
Venus Medtech
Suzhou Jiecheng Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Stented Biological Valve product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Stented Biological Valve, with price, sales quantity, revenue, and global market share of Stented Biological Valve from 2020 to 2025.
Chapter 3, the Stented Biological Valve competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Stented Biological Valve breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Stented Biological Valve market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Stented Biological Valve.
Chapter 14 and 15, to describe Stented Biological Valve sales channel, distributors, customers, research findings and conclusion.
A Stented Biological Valve is a type of bioprosthetic heart valve that incorporates a metallic or polymeric stent to hold the valve in place. These valves are made from animal tissues (bovine or porcine) and are designed for patients who require a valve replacement but do not wish to take long-term anticoagulants.
Market Overview:
Stented biological valves are among the most commonly used valves in heart valve replacement surgeries. They are widely used due to their natural function, low risk of thromboembolic events, and favorable clinical outcomes. The addition of a stent allows for easier implantation, particularly in older patients and those undergoing transcatheter procedures.
Market Drivers:
Preference for biological valves over mechanical valves due to their natural function and reduced need for anticoagulation.
Increasing adoption of minimally invasive approaches like TAVR, where stented biological valves are often preferred.
Aging populations and the rising incidence of valvular heart disease.
Market Opportunities:
Expanding indications for the use of stented biological valves in various procedures, particularly in lower-risk patient populations.
Research into improving the longevity and anti-calcification properties of stented valves.
Market Limitations:
Limited durability compared to mechanical valves, which may require reoperation in younger patients.
Concerns about the risk of degeneration and calcification, particularly in patients under 65 years old.
Market Trends:
Greater adoption of TAVR procedures, leading to a rise in the use of stented biological valves.
Ongoing improvements in the durability and biocompatibility of stented biological valves.
This report is a detailed and comprehensive analysis for global Stented Biological Valve market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Stented Biological Valve market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Stented Biological Valve market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Stented Biological Valve
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Stented Biological Valve market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Edwards Lifesciences, St. Jude Medical, Meril Life Sciences, Boston Scientific, Labor, Abbott, Colibri Heart Valve, Balance Medical, Venus Medtech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Stented Biological Valve market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Surgical Valve
Interventional Valve
Market segment by Application
Hospital
Clinic
Other
Major players covered
Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Boston Scientific
Labor
Abbott
Colibri Heart Valve
Balance Medical
Venus Medtech
Suzhou Jiecheng Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Stented Biological Valve product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Stented Biological Valve, with price, sales quantity, revenue, and global market share of Stented Biological Valve from 2020 to 2025.
Chapter 3, the Stented Biological Valve competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Stented Biological Valve breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Stented Biological Valve market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Stented Biological Valve.
Chapter 14 and 15, to describe Stented Biological Valve sales channel, distributors, customers, research findings and conclusion.
Table of Contents
115 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Stented Biological Valve by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
